QUETIAPINE FUMARATE 300 mg/1

Quetiapine Fumarate 300 mg Extended Release Tablets are an atypical antipsychotic medication used to manage various mental health conditions. This extended-release formulation is designed for oral administration and is manufactured by Accord Healthcare Inc.

Quetiapine Fumarate is commonly used to treat symptoms associated with schizophrenia and bipolar disorder. It may also be prescribed for other mental health conditions as determined by a healthcare provider. The extended-release formulation is intended to provide a steady release of the medication over time.

Quetiapine Fumarate may cause drowsiness, dizziness, and dry mouth. Some users report weight gain and changes in appetite. It is important to monitor for any unusual side effects and consult a healthcare provider if they occur.

Quetiapine Fumarate should be handled with care, especially by individuals with a history of low blood pressure, heart disease, or seizures. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional.

Quetiapine Fumarate may interact with alcohol, other antipsychotics, and medications that affect the central nervous system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.